Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-04T18:38:43.289Z Has data issue: false hasContentIssue false
  • English
  • Français

Beauty and the Beast: Psychobiologic and Evolutionary Perspectives on Body Dysmorphic Disorder

Published online by Cambridge University Press:  07 November 2014

Dan J. Stein ,
Paul D. Carey  and
James Warwick
Get access Rights & Permissions [Opens in a new window]

Abstract

Body dysmorphic disorder (BDD) is characterized by preoccupation with a defect in appearance. Concepts of beauty play a particularly crucial role in humans' mental and social life, and may have specific psychobiologic and evolutionary underpinnings. In particular, there is a growing literature on the neurocircuitry underpinning the body schema, body image and facial expression processing, and aesthetic and symmetry judgments. Speculatively, disruptions in cognitive-affective processes relevant to judgments about physical beauty lead to BDD.

Type
Pearls in Clinical Neuroscience
Information
CNS Spectrums , Volume 11 , Issue 6 , June 2006 , pp. 419 - 422
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.McGlynn, SM, Schachter, DL. Unawareness of deficits in neuropsychological syndromes. J Clin Exp Neuropsychol. 1989;11:143–205.CrossRefGoogle ScholarPubMed
2.Maravita, A, Spence, C, Driver, J. Multisensory integration and the body schema: Close to hand and within reach. Curr Biol. 2003;13:531–539.Google Scholar
3.Downing, PE, Jiang, Y, Shuman, M, Kanwisher, D. A cortical area selective for visual processing of the human body. Science. 2001;293:2470–2473.Google Scholar
4.Uher, R, Murphy, T, Friederich, HC, et al.Functional neuroanatomy of body shape perception in healthy and eating-disordered women. Biol Psychiatry. 2005;58:990–997.Google Scholar
5.Loffler, G, Yourganov, G, Wilkinson, F, Wilson, HR. fMRI evidence for the neural representation of faces. Nat Neurosci. 2005;8:1386–1390.Google Scholar
6.Grill-Spector, K, Knouf, N, Kanwisher, N. The fusiform face area subserves face perception, not generic within-category identification. Nat Neurosci. 2004;7:555–562.Google Scholar
7.Aharon, I, Etcoff, N, Ariely, D, Chabris, CF, O'Connor, E, Breiter, HC. Beautiful faces have variable reward value: fMRI and behavioral evidence. Neuron. 2001;32:537–551.Google Scholar
8.O'Doherty, J, Winston, J, Critchley, H, Perrett, D, Burt, DM, Dolan, RJ. Beauty in a smile: the role of medial orbitofrontal cortex in facial attractiveness. Neuropsychologia. 2003;41:147–155.Google Scholar
9.Jacobsen, T, Schubotz, RI, Hofel, L, Cramon, DY. Brain correlates of aesthetic judgment of beauty. Neuroimage. 2006;29:276–285.CrossRefGoogle ScholarPubMed
10.Senior, C. Beauty in the brain of the beholder. Neuron. 2003;38:525–528.Google Scholar
11.Rauch, SL, Phillips, KA, Segal, E, et al.A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder. Psychiatry Res. 2003;122:13–19.Google Scholar
12.Carey, P, Seedat, S, Warwick, J, van Heerden, B, Stein, DJ. SPECT imaging of body dysmorphic disorder. J Neuropsychiatry Clin Neurosci. 2004;16:357–359.Google Scholar
13.Deckersbach, T, Savage, CR, Phillips, KA, et al.Characteristics of memory dysfunction in body dysmorphic disorder. J Int Neumpsychol Soc. 2000;6:673–681.Google Scholar
14.Gabbay, V, Asnis, GM, Bello, JA, Alonso, CM, Serras, SJ, O'Dowd, MA. New onset of body dysmorphic disorder following frontotemporal lesion. Neurology. 2003;61:123–125.Google Scholar
15.Hollander, E, Allen, A, Kwon, J, et al.Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry. 1999;56:1033–1039.CrossRefGoogle ScholarPubMed
16.Phillips, KA, McElray, SL, Dwight, MM, Eisen, JL, Rasmussen, SA. Delusionality and response to open-label fluvoxamine in body dysmorphic disorder. J Clin Psychiatry. 2001;62:87–91.Google Scholar
17.Phillips, KA. Olanzapine augmentation of fluoxetine in body dysmorphic disorder. Am J Psychiatry. 2005;162:1022–1023.Google Scholar
18.Veale, D, Gournay, K, Dryden, W, Boocock, A, Shah, F, Willson, R, Walburn, J. Body dysmorphic disorder: a cognitive behavioural model and pilot randomised controlled trial. Behav Res Ther. 1996;34:717–729.CrossRefGoogle ScholarPubMed
19.Greer, JM, Capecchi, MR. Hoxb8 is required for normal grooming behavior in mice. Neuron. 2002;33:23–34.Google Scholar
20.Phillips, KA, Menard, W, Fay, C, Weisberg, R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics. 2005;46:317–325.Google Scholar
21.Bienvenu, OJ, Samuels, JF, Riddle, MA, et al.The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry. 2000;48:287–293.Google Scholar
22.Roberts, SC, Little, AC, Gosling, LM, et al.MHC-heterozygosity and human facial attractiveness. Evol Hum Behav. 2005;26:213–216.Google Scholar
23.Stein, DJ, Frenkel, M, Hollander, E. Classification of Koro. Am J Psychiatry. 1991;148:1279–1280.Google Scholar
24.Hitzeroth, V, Wessels, C, Zungu-Dirwayi, N, Oosthuizen, P, Stein, DJ. Muscle dysmorphia: a South African sample. Psychiatry Clin Neurosci. 2001;55:521–523.Google Scholar
25.Rhodes, G, Yoshikawa, S, Clark, A, Lee, K, McKay, R, Akamatsu, S. Attractiveness of facial averageness and symmetry in non-western cultures: in search of biologically based standards of beauty. Perception. 2001;30:611–625.Google Scholar
26.Rhodes, G. The evolutionary psychology of facial beauty. Annu Rev Psychol. 2006;57:199–226.Google Scholar
27.Etcoff, N. Survival of the Prettiest: The Science of Beauty. New York, NY: Anchor/Doubleday; 1999.Google Scholar
28.Zaidel, DW, Aarde, SM, Baig, K. Appearance of symmetry, beauty, and health in human faces. Brain Cogn. 2005;57:261–263.Google Scholar
29.Cellerino, A. Psychobiology of facial attractiveness. J Endocrinol Invest. 2003;26(3 suppl):45–48.Google Scholar
30.Thornhill, R, Gangestad, SW. Facial attractiveness. Trends Cog Sci. 1999;3:452–460.CrossRefGoogle ScholarPubMed
31.Stein, DJ. Translational and evolutionary models of body dysmorphic disorder. In: Maj, M, Akiskal, HS, Mezzich, JE, Okasha, A, eds. Somatoform Disorders. Chichester, England: John Wiley; 2005;226–227.Google Scholar
32.Veale, D, Ennis, M, Lambrou, C. Possible association of body dysmorphic disorder with an occupation or education in art and design. Am J Psychiatry. 2002;159:1788–1790.Google Scholar
33.Atiullah, N, Phillips, KA. Fatal body dysmorphic disorder by proxy. J Clin Psychiatry. 2001;62:204–205.Google Scholar
34.Phillips, KA. Body dsymorphic disorder: diagnostic controversies and treatment challenges. Bull Menninger Clin. 2000;64:18–35.Google Scholar
35.Simeon, D, Hollander, E, Stein, DJ, Cohen, L, Aronowitz, B. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. Am J Psychiatry. 1995;152:1207–1209.Google ScholarPubMed
36.Stein, DJ, Ono, Y, Tajima, O, Muller, JE. The social anxiety disorder spectrum. J Clin Psychiatry. 2004;65:27–33.Google Scholar
37.Phillips, KA, Menard, W, Pagano, ME, Fay, C, Stout, RL. Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness. J Psychiatr Res. 2006;40:95–104.Google Scholar
38.Zimmerman, M, Mattia, JI. Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates. Compr Psychiatry. 1998;39:265–270.Google Scholar
39.Wilhelm, S, Otto, MW, Zucker, BG, Pollack, MH. Prevalence of body dysmorphic disorder in patients with anxiety disorders. J Anxiety Disord. 1997;11:499–502.Google Scholar
40.Grant, JE, Kim, SW, Crow, SJ. Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. J Clin Psychiatry. 2001;62:517–522.Google Scholar
41.Otto, MW, Wilhelm, S, Cohen, LS, Harlow, BL. Prevalence of body dysmorphic disorder in a community sample of women. Am J Psychiatry. 2001;58:2061–2063.Google Scholar
42.Dufresne, RG, Phillips, KA, Vittorio, CC, Wilkel, CS. A screening questionnaire for body dysmorphic disorder in a cosmetic dermatologic surgery practice. Dermatol Surg. 2001;27:457–462.Google Scholar
43.Phillips, KA, Hollander, E, Rasmussen, SA, Aronowitz, BR, DeCaria, C, Goodman, WK. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull. 1997;33:17–22.Google ScholarPubMed
44.Phillips, KA, Coles, ME, Menard, W, Yen, S, Fay, C, Weisberg, RB. Suicidal ideation and suicide attempts in body dysmorphic disorder. J Clin Psychiatry. 2005;66:717–725.Google Scholar
45.Phillips, KA, Taub, SL. Skin picking as a symptom of body dysmorphic disorder. Psychopharmacol Bull. 1995;31:279–288.Google Scholar
46.Lucas, P. Violence may be serious in men with body dysmorphic disorder. BMJ. 2002;324:678.Google Scholar
47.Williams, J, Hadjistavropoulos, T, Sharpe, D. A meta-analysis of psychological and pharmacological treatments for Body Dysmorphic Disorder. Behav Res Ther. 2006;44:99–111.Google Scholar
48.Phillips, KA. Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder. Am J Psychiatry. 2005;162:377–379.Google Scholar